These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35806286)

  • 1. MicroRNA Methylome Signature and Their Functional Roles in Colorectal Cancer Diagnosis, Prognosis, and Chemoresistance.
    Baharudin R; Rus Bakarurraini NQ; Ismail I; Lee LH; Ab Mutalib NS
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in epigenetic biomarker research in colorectal cancer.
    Wang X; Kuang YY; Hu XT
    World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.
    Okugawa Y; Grady WM; Goel A
    Gastroenterology; 2015 Oct; 149(5):1204-1225.e12. PubMed ID: 26216839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer.
    Zhang X; Hou H; Jiang M; Zhang X
    Mol Biol Rep; 2023 Mar; 50(3):2743-2750. PubMed ID: 36583782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Methylation in Colorectal Cancer.
    Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
    Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
    Toiyama Y; Okugawa Y; Goel A
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of methylation markers in colorectal cancer (Review).
    Kong C; Fu T
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34212989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMT1 maintains the methylation of miR-152-3p to regulate TMSB10 expression, thereby affecting the biological characteristics of colorectal cancer cells.
    Wang C; Ma X; Zhang J; Jia X; Huang M
    IUBMB Life; 2020 Nov; 72(11):2432-2443. PubMed ID: 32918845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
    Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
    Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance.
    Zhao N; Lai C; Wang Y; Dai S; Gu H
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189096. PubMed ID: 38499079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.
    Fatemi N; Tierling S; Es HA; Varkiani M; Mojarad EN; Aghdaei HA; Walter J; Totonchi M
    Int J Cancer; 2022 Dec; 151(12):2068-2081. PubMed ID: 35730647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.
    Anwar SL; Lehmann U
    World J Gastroenterol; 2014 Jun; 20(24):7894-913. PubMed ID: 24976726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
    Perakis SO; Thomas JE; Pichler M
    Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Methylation Biomarkers for Colorectal Cancer Prognosis.
    Gutierrez A; Demond H; Brebi P; Ili CG
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance.
    Massaro C; Safadeh E; Sgueglia G; Stunnenberg HG; Altucci L; Dell'Aversana C
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assimilating Epigenetics and Transcriptomics for the Identification of Prognostic Novel Biomarkers and Imminent Targets in Colorectal Carcinoma with Therapeutic Potential.
    Ray SK; Mukherjee S
    Curr Mol Med; 2023; 23(8):784-798. PubMed ID: 35546765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic biomarkers in colorectal cancer diagnostics.
    Rawson JB; Bapat B
    Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.